Prevalence of fluoroquinolone-resistant Salmonella serotypes in Iran: a meta-analysis

Farzad Khademi1, Hamid Vaez2, Fahimeh Ghanbari3

  • 1Department of Microbiology, School of Medicine, Ardabil University of Medical Sciences, Ardabil, Iran.

Insights

Antimicrobial resistance in Salmonella is increasing in Iran, particularly fluoroquinolone resistance. While older antibiotics are failing, newer drugs like ciprofloxacin and carbapenems remain effective against resistant strains.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Public Health

Background:

  • Salmonella serotypes are a significant cause of bacterial infections globally.
  • Fluoroquinolone resistance in Salmonella is a growing public health concern.
  • Understanding antimicrobial susceptibility patterns is crucial for effective treatment strategies.

Purpose of the Study:

  • To investigate the antimicrobial susceptibility profiles of Salmonella serotypes in clinical samples from Iran.
  • To specifically assess the prevalence and patterns of fluoroquinolone-resistant Salmonella strains.
  • To evaluate the trends in resistance to commonly used antibiotics for Salmonella infections.

Main Methods:

  • A systematic literature review was conducted using major scientific databases (ISI Web of Knowledge, PubMed, Scopus, Google Scholar, SID).
  • Search terms included "Salmonella", "antimicrobial resistance", "fluoroquinolone", and "Iran" in Persian and English.
  • Data from 46 eligible articles published between 1983 and July 2019 were analyzed.

Main Results:

  • The pooled prevalence of quinolone-resistant Salmonella was 2.9% for ciprofloxacin and 48.1% for nalidixic acid.
  • High resistance rates were observed for tetracycline (54.3%), ceftizoxime (50.6%), and streptomycin (50.2%).
  • Resistance to first-line drugs like ampicillin (37.9%), chloramphenicol (27.2%), and trimethoprim-sulfamethoxazole (33.5%) is increasing.

Conclusions:

  • There is a concerning rise in antimicrobial resistance among Salmonella serotypes in Iran, impacting treatment efficacy.
  • While resistance to older antibiotics is high, ciprofloxacin, third-generation cephalosporins, and carbapenems show continued effectiveness, particularly against multi-drug resistant strains.
  • Continued surveillance and strategic antibiotic use are essential to combat Salmonella resistance in the region.